Women Overdue for Cancer Screenings

Overview

A significant number of US women aged 45 to 64 are overdue for cancer screenings, with nearly 18 million women missing at least one recommended screening. The study highlights the need for targeted outreach and improved access to healthcare services to address these gaps.

Background

Cancer remains a leading cause of mortality among women aged 45 to 64 in the United States, making timely screenings for breast, cervical, and colorectal cancers crucial. Despite the availability of effective screening methods, many women in this age group are not up to date with their screenings, which can lead to late-stage diagnoses and increased mortality. Understanding the factors associated with screening participation is essential for improving public health outcomes.

Data Highlights

Key Findings

• Approximately 17.9 million women aged 45 to 64 are overdue for at least one cancer screening.
• Colorectal cancer screening has the largest unmet need, with 12.6 million women overdue.
• 52% of women overdue for colorectal screening were also overdue for breast and/or cervical screenings.
• Access-related factors, including insurance coverage and regular healthcare access, significantly influence screening participation.
• Women aged 45 to 49 years represent a key target group for outreach, particularly for colorectal cancer screening.

Clinical Implications

Healthcare providers should prioritize outreach efforts to women aged 45 to 64, particularly those lacking insurance or regular healthcare access. Integrating cancer screening discussions into routine wellness visits may help address multiple screening needs simultaneously, improving overall compliance.

Conclusion

Addressing the significant number of women overdue for cancer screenings requires targeted interventions and improved access to healthcare resources. Enhanced awareness and coordinated outreach can lead to better screening rates and ultimately reduce cancer-related mortality.

Related Resources & Content

1. JAMA Network Open, 2024 -- Women Overdue for Cancer Screenings
2. The ASCO Post, 2025 -- Rates of Breast, CRC Screenings Almost Four Times Higher Than Lung Cancer Screenings
3. The ASCO Post, 2025 -- Low-Value Cancer Screenings May Continue for Years Following Guideline Change to Limit Unnecessary Tests
4. The ASCO Post — Screening Younger Women for Variants Linked to Breast and Ovarian Cancers May Be Cost-Effective
5. Breast Cancer: Screening | United States Preventive Services Taskforce
6. U.S. Multi-Society Task Force on CRC releases updated screening recommendations
7. Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force | Breast Cancer | JAMA | JAMA Network